Ngam Advisors L.P. boosted its position in Monsanto Company (NYSE:MON) by 2.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 18,417 shares of the basic materials company’s stock after buying an additional 497 shares during the period. Ngam Advisors L.P.’s holdings in Monsanto were worth $2,085,000 as of its most recent filing with the SEC.
A number of other institutional investors have also recently modified their holdings of the company. HighPoint Advisor Group LLC increased its stake in shares of Monsanto by 11.4% in the fourth quarter. HighPoint Advisor Group LLC now owns 2,472 shares of the basic materials company’s stock valued at $286,000 after buying an additional 253 shares in the last quarter. Israel Discount Bank of New York GFN bought a new stake in shares of Monsanto during the fourth quarter valued at $140,000. Norges Bank bought a new stake in shares of Monsanto during the fourth quarter valued at $406,735,000. Sowell Financial Services LLC bought a new stake in shares of Monsanto during the fourth quarter valued at $480,000. Finally, Luminus Management LLC bought a new stake in shares of Monsanto during the fourth quarter valued at $14,596,000. Institutional investors own 75.31% of the company’s stock.
Monsanto Company (NYSE MON) traded down 0.16% during mid-day trading on Tuesday, hitting $117.26. 1,147,450 shares of the stock traded hands. The company has a market cap of $51.52 billion, a price-to-earnings ratio of 25.33 and a beta of 1.07. Monsanto Company has a 12 month low of $97.35 and a 12 month high of $118.97. The stock’s 50 day moving average is $117.53 and its 200-day moving average is $114.77.
Monsanto (NYSE:MON) last announced its quarterly earnings data on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.74 by $0.19. The business had revenue of $4.23 billion for the quarter, compared to the consensus estimate of $4.18 billion. Monsanto had a net margin of 14.11% and a return on equity of 45.26%. The company’s quarterly revenue was up 1.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.17 earnings per share. On average, equities research analysts anticipate that Monsanto Company will post $4.89 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, July 28th. Investors of record on Friday, July 7th were paid a dividend of $0.54 per share. This represents a $2.16 annualized dividend and a dividend yield of 1.84%. The ex-dividend date was Wednesday, July 5th. Monsanto’s payout ratio is 46.75%.
COPYRIGHT VIOLATION NOTICE: “Monsanto Company (MON) Position Boosted by Ngam Advisors L.P.” was published by Markets Daily and is the sole property of of Markets Daily. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.themarketsdaily.com/2017/08/08/ngam-advisors-l-p-increases-position-in-monsanto-company-mon-updated-updated-updated.html.
A number of research firms have recently commented on MON. Royal Bank Of Canada restated a “sector perform” rating and set a $128.00 target price (up from $120.00) on shares of Monsanto in a research report on Thursday, June 29th. Zacks Investment Research upgraded Monsanto from a “hold” rating to a “buy” rating and set a $132.00 target price on the stock in a research report on Friday, June 16th. Jefferies Group LLC cut Monsanto from a “buy” rating to a “hold” rating and set a $128.00 target price on the stock. in a research report on Wednesday, July 12th. Vetr upgraded Monsanto from a “hold” rating to a “buy” rating and set a $122.35 target price on the stock in a research report on Wednesday, July 12th. Finally, Citigroup Inc. restated a “neutral” rating and set a $125.00 target price (up from $122.00) on shares of Monsanto in a research report on Friday, April 14th. Two investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and eight have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $123.15.
In related news, EVP Steven Mizell sold 11,300 shares of the company’s stock in a transaction that occurred on Monday, July 3rd. The shares were sold at an average price of $118.57, for a total transaction of $1,339,841.00. Following the transaction, the executive vice president now owns 55,011 shares of the company’s stock, valued at $6,522,654.27. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Janet M. Holloway sold 7,423 shares of the stock in a transaction that occurred on Tuesday, June 13th. The stock was sold at an average price of $118.00, for a total transaction of $875,914.00. Following the transaction, the senior vice president now directly owns 33,645 shares in the company, valued at approximately $3,970,110. The disclosure for this sale can be found here. Insiders have sold 74,470 shares of company stock worth $8,791,281 in the last three months. Insiders own 0.79% of the company’s stock.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.